← Back to Clinical Trials
Recruiting NCT04662190
Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.
Trial Parameters
Condition Thyroid Associated Ophthalmopathy
Sponsor Althaia Xarxa Assistencial Universitària de Manresa
Study Type INTERVENTIONAL
Phase N/A
Enrollment 12
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-07-05
Completion 2025-12
All Conditions
Interventions
3D printing model/guide.Standard surgery
Brief Summary
This is a multicentric, randomized, single-blinded clinical trial to evaluate the efficacy and safety of 3D printing for the planification and simulation of orbital decompression surgery for thyroid-associated orbitopathy.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of inactive thyroid-associated orbitopathy requiring bilateral orbital decompression (moderate-severe in EUGOGO classification). * Volunteers older than 18 years old. * Ability to read. * Acceptation to participate and signature of informed consent. Exclusion Criteria: * Younger than 18 years old. * Previous orbital surgery. * Any coexisting disease preventing follow-up.
Related Trials
NCT04662190
Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.
View Trial →
NCT04936854
Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease
View Trial →
NCT07124572
Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophtha
View Trial →